BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 25931285)

  • 1. DNA damage in cancer therapeutics: a boon or a curse?
    Khanna A
    Cancer Res; 2015 Jun; 75(11):2133-8. PubMed ID: 25931285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
    Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
    Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unconventional role of BMP-Smad1 signaling in DNA damage response: a mechanism for tumor suppression.
    Liu H; Bao D; Xia X; Chau JF; Li B
    J Cell Biochem; 2014 Mar; 115(3):450-6. PubMed ID: 24142423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic instability as a driver for oncogenesis].
    Cazaux C
    Bull Cancer; 2010 Nov; 97(11):1241-51. PubMed ID: 21084240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
    Goldstein M; Kastan MB
    Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs, DNA Damage Response, and Cancer Treatment.
    He M; Zhou W; Li C; Guo M
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
    Kinsella TJ
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidatively induced DNA damage: mechanisms, repair and disease.
    Dizdaroglu M
    Cancer Lett; 2012 Dec; 327(1-2):26-47. PubMed ID: 22293091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage response: the players, the network and the role in tumor suppression.
    Rai R; Peng G; Li K; Lin SY
    Cancer Genomics Proteomics; 2007; 4(2):99-106. PubMed ID: 17804872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of DNA damage checkpoints in the pathogenesis of human cancers.
    Poehlmann A; Roessner A
    Pathol Res Pract; 2010 Sep; 206(9):591-601. PubMed ID: 20674189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting DNA Repair.
    Curigliano G
    Handb Exp Pharmacol; 2018; 249():161-180. PubMed ID: 30341723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the DNA Damage Response in Cancer.
    O'Connor MJ
    Mol Cell; 2015 Nov; 60(4):547-60. PubMed ID: 26590714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage Response.
    Hazan I; Hofmann TG; Aqeilan RI
    PLoS Genet; 2016 Dec; 12(12):e1006436. PubMed ID: 27977694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA damage response pathway in normal hematopoiesis and malignancies.
    Delia D; Mizutani S
    Int J Hematol; 2017 Sep; 106(3):328-334. PubMed ID: 28707218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
    Bartkova J; Horejsí Z; Koed K; Krämer A; Tort F; Zieger K; Guldberg P; Sehested M; Nesland JM; Lukas C; Ørntoft T; Lukas J; Bartek J
    Nature; 2005 Apr; 434(7035):864-70. PubMed ID: 15829956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage checkpoint recovery and cancer development.
    Wang H; Zhang X; Teng L; Legerski RJ
    Exp Cell Res; 2015 Jun; 334(2):350-8. PubMed ID: 25842165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage response and prostate cancer: defects, regulation and therapeutic implications.
    Karanika S; Karantanos T; Li L; Corn PG; Thompson TC
    Oncogene; 2015 May; 34(22):2815-22. PubMed ID: 25132269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding cancer development processes after HZE-particle exposure: roles of ROS, DNA damage repair and inflammation.
    Sridharan DM; Asaithamby A; Bailey SM; Costes SV; Doetsch PW; Dynan WS; Kronenberg A; Rithidech KN; Saha J; Snijders AM; Werner E; Wiese C; Cucinotta FA; Pluth JM
    Radiat Res; 2015 Jan; 183(1):1-26. PubMed ID: 25564719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.